- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics ; volume:10 ; number:2 ; day:12 ; month:4 ; year:2012 ; pages:1 ; date:12.2012
Hereditary cancer in clinical practice ; 10, Heft 2 (12.4.2012), 1, 12.2012
- Urheber
-
Oakes, SR
- Beteiligte Personen und Organisationen
-
Vaillant, F.
Lim, E.
Lee, L.
Breslin, K.
Feleppa, F.
Deb, S.
Ritchie, ME
Takano, E.
Ward, T.
Fox, SB
Generali, D.
Smyth, GK
Strasser, A.
Huang, DCS
Visvader, JE
Lindeman, GJ
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-10-S2-A25
- URN
-
urn:nbn:de:1111-2016073117786
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Oakes, SR
- Vaillant, F.
- Lim, E.
- Lee, L.
- Breslin, K.
- Feleppa, F.
- Deb, S.
- Ritchie, ME
- Takano, E.
- Ward, T.
- Fox, SB
- Generali, D.
- Smyth, GK
- Strasser, A.
- Huang, DCS
- Visvader, JE
- Lindeman, GJ
- SpringerLink (Online service)
Ähnliche Objekte (12)
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
BH3-mimetics: recent developments in cancer therapy
A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
BH3 mimetics for the treatment of prostate cancer
Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia